RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression

被引：0
作者：
Yanyan Wang
Yun-Ling Tai
Grayson Way
Jing Zeng
Derrick Zhao
Lianyong Su
Xixian Jiang
Kaitlyn G. Jackson
Xuan Wang
Emily C. Gurley
Jinze Liu
Jinpeng Liu
Weidong Chen
Xiang-Yang Wang
Arun J. Sanyal
Phillip B. Hylemon
Huiping Zhou
机构：
[1] Virginia Commonwealth University School of Medicine,Department of Microbiology & Immunology
[2] Virginia Commonwealth University,McGuire Veterans Affairs Medical Center
[3] Anhui University of Chinese Medicine,School of Pharmaceutical Science
[4] Virginia Commonwealth University,Center for Clinical and Translational Research
[5] Virginia Commonwealth University,Department of Biostatistics
[6] University of Kentucky,Department of Computer Science
[7] Virginia Commonwealth University School of Medicine,Department of Human & Molecular Genetics
[8] Virginia Commonwealth University School of Medicine,Institute of Molecular Medicine
[9] Virginia Commonwealth University School of Medicine,Massey Cancer Center
[10] Virginia Commonwealth University School of Medicine,Department of Internal Medicine/GI Division
来源：
Cell & Bioscience | / 12卷
关键词：
Bile acids; NASH; Inflammation; Sphingosine kinase; Sphingosine-1 phosphate receptor 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 229 条
[1]  
Lazarus JV(2022)Advancing the global public health agenda for NAFLD: a consensus statement Nat Rev Gastroenterol Hepatol 19 60-78
[2]  
Mark HE(2021)Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade Hepatology 73 833-842
[3]  
Anstee QM(2021)Epidemiology of hepatocellular carcinoma Hepatology 73 4-13
[4]  
Arab JP(2021)Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol 18 223-238
[5]  
Batterham RL(2021)NAFLD as a metabolic disease in humans: a literature review Diabetes Obes Metab 69 1691-1705
[6]  
Castera L(2020)NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications Gut 24 908-922
[7]  
Tilg H(2018)Mechanisms of NAFLD development and therapeutic strategies Nat Med 3 176-183
[8]  
Adolph TE(2017)Sphingosine kinases/sphingosine 1-phosphate signaling in hepatic lipid metabolism Curr Pharmacol Rep 62 135-146
[9]  
Moschen AR(2015)Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice Hepatology 61 1216-1226
[10]  
McGlynn KA(2015)Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression Hepatology 24 1399-1412
12345678910